Perspective Therapeutics (CATX) Accounts Payables (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Accounts Payables for 15 consecutive years, with $20.5 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 98.31% to $20.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.5 million through Dec 2025, up 98.31% year-over-year, with the annual reading at $20.5 million for FY2025, 98.31% up from the prior year.
  • Accounts Payables hit $20.5 million in Q4 2025 for Perspective Therapeutics, up from $13.1 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $21.8 million in Q3 2024 to a low of $98000.0 in Q2 2021.
  • Historically, Accounts Payables has averaged $6.0 million across 5 years, with a median of $4.4 million in 2023.
  • Biggest five-year swings in Accounts Payables: tumbled 87.4% in 2022 and later surged 3170.67% in 2023.
  • Year by year, Accounts Payables stood at $153000.0 in 2021, then soared by 907.19% to $1.5 million in 2022, then soared by 348.35% to $6.9 million in 2023, then surged by 49.7% to $10.3 million in 2024, then skyrocketed by 98.31% to $20.5 million in 2025.
  • Business Quant data shows Accounts Payables for CATX at $20.5 million in Q4 2025, $13.1 million in Q3 2025, and $7.0 million in Q2 2025.